The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer

63Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

Abstract

Glypican-1 (GPC-1) and other glypicans are a family of heparan sulfate proteoglycans. These proteins are highly expressed on the cell membrane and in the extracellular matrix, functioning mainly as modulators of growth factor signaling. Some of them are abnormally expressed in cancer, possibly involved in tumorigenesis, and detectable in blood as potential clinical biomarkers. GPC-1 is another glypican member that has been found to be associated with some cancers, and has increasingly interested the cancer field. Here we provide a brief review about GPC-1 in its expression, signaling and potential as a cancer biomarker.

Cite

CITATION STYLE

APA

Wang, S., Qiu, Y., & Bai, B. (2019, July 12). The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2019.00614

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free